Summary
Invasion requires a number of distinct tumor cell interactions with host tissue, beginning with attachment to the matrix, followed by hydrolysis of matrix material and locomotion. Gene products which may be involved in these steps are discussed here. Laminin receptors and integrins have roles in the adhesion phase, while certain collagenases are prominent among the matrix-degrading enzymes. Autocrine motility factors, distinct from growth factors, appear to be involved in tumor cell locomotion. Finally, certain oncogenes, partricularly of theras family, are closely related with metastatic potential. A detailed understanding of the molecular biology of invasion and metastasis could ultimately lead to specific means of interfering with or even reversing these malignant processes.
Similar content being viewed by others
References
Sugarbaker EV: Patterns of metastasis in human malignancies. Cancer Biol Rev 2: 235, 1981
Weiss L, Gilbert HA: Bone Metastases. GK Hall, Medical Publishers, Boston, 1981
Schirrmacher V: Cancer metastasis: Experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 43: 1–73, 1985
Liotta LA: Tumor invasion and metastases — role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46: 1, 1986
Barsky SH, Siegal GP, Jannotta F, Liotta LA: Loss of basement membrane components by invasive tumors but not their benign counterparts. Lab Invest 49: 140–148, 1983
Forester SJ, Talbot IC, Critshley DR: Laminin and fibronectin in rectal adenocarcinoma: Relationship to tumor grade, stage and metastasis. Br J Cancer 50: 51–61, 1984
Wewer UM, Liotta LA, Jaye M,et al.: Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc Natl Acad Sci USA 83: 7137, 1986
Rao CN, Margulies IM, Tralken S,et al.: Isolation of a subunit of laminin and its role in molecular structure and tumor cell attachment. J Biol Chem 257: 9740–9750, 1982
Engel J, Odermatt E, Engel A,et al.: Shapes, domain, organization, and flexibility of laminin and fibronectin, two multifunctional proteins of the ECM. J Mol Biol 150: 97–108, 1981
Barsky SH, Rao CN, William JE, Liotta LA: Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 74: 843–848, 1984
Hynes RO: Integrins: A family of cell surface receptors. Cell 48: 549, 1987
Furcht LT: Editorial: Critical factors controlling angiogenesis: Cell products, cell matrix, and growth factors. Lab Invest 55: 505, 1986
Thorgeirsson UP, Turpeenniemi-Hujanen T, Neckers LM, Johnson DW, Liotta LA: Protein synthesis but not DNA synthesis is required for tumor cell invasionin vitro. Invas Metast 4: 73–83, 1984
Liotta, LA, Thorgeirsson UP, Garbisa S: Role of collagenases in tumor cell invasion. Cancer Metast Rev 1: 277–288, 1982
Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261: 6600–6605, 1986
Fini ME, Plucinska IM, Mayer AS, Gross RH, Brinckerhoff CE: A gene for rabbit synovial cell collagenase: Member of a family of metalloproteinases that degrade the connective tissue matrix. Biochemistry 26: 6156–6165, 1987
Huang C-C, Blitzer A, Abramson M: Collagenase in human head and neck tumors and rat tumors and fibroblasts in monolayer cultures. Ann Otol Rhinol Laryngol 95: 158–161, 1986
Fessler LI, Duncan KG, Fessler JH: Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J Biol Chem 259: 9783–9789, 1984
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67–68, 1980
Sloane BF, Honn KV: Cysteine proteinases and metastasis. Cancer Metast Rev 3: 249–263, 1984
Weinberg RA: Oncogenes of spontaneous and chemically induced tumors. Adv Cancer Res 36: 149–156, 1982
Hunter T: Oncogenes and proto-oncogenes: How do they differ? J Natl Cancer Inst 73: 773–786, 1984
Chang EH, Furth ME, Scolnick EM, Lowry DR: Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Proc Natl Acad Sci USA 78: 3328–3332, 1981
Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 47: 1473–1487, 1987
Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westin EH, Heilman CA, Talmadge JE, Liotta LA: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5: 259–262, 1985
Muschel RJ, Williams JE, Lowry DR, Liotta LA: Harveyras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am J Pathol 121: 1–8, 1985
Bondy GP, Wilson S, Chambers AF: Experimental metastatic ability of H-ras transformed NIH-3T3 cells. Cancer Res 45: 6005–6009, 1985
Greig RG, Koestler TP, Trainer DL, Corwin SP, Miles L, Kline T, Sweet R, Yokoyama S, Poste G: Tumorigenic and metastatic properties of ‘normal’ andras-transfected NIH/3T3 cells. Proc Natl Acad Sci USA 82: 3698–3701, 1985
Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro I, Hager G, Greenberg AH: Expression of H-ras correlates with metastatic potential: Evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells. Mol Cell Biol 7: 830–837, 1987
Vousden KH, Eccles SA, Purvies H, Marshall CJ: Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene. Int J Cancer 37: 425–433, 1986
Kerbel RS, Waghorne C, Man MS, Elliott B, Breitman ML: Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection. Proc Natl Acad Sci USA 84: 1263–1267, 1987
Collard JG, Schijven JF, Roos E: Invasive and metastatic potential induced byras-transfection into mouse BW5147 T-lymphoma cells. Cancer Res 47: 754–759, 1987
Muschel RJ, Nakahara K, Chu E, Pozzatti R, Liotta LA: Karyotypic analysis of diploid or near diploid metastatic Harveyras transformed rat embryo fibroblasts. Cancer Res 46: 4104–4108, 1986
Pozzatti R, Muschel R, Williams J, Padmanabhan R, Howard B, Liotta L, Khoury G: Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 232: 223–227, 1986
Gullino PM, Pettigrew NM, Grantharn FH: N-nitroso-methylurea as a mammary gland carcinoma in rats. J Natl Cancer Inst 54: 401–409, 1975
Sukumar S, Notario V, Martin-Zanca D,et al.: Induction of mammary carcinomas in rats by NMU involves malignant activation of Ha-ras-1 locus by a single point mutation. Nature 306: 658–661, 1983
Garbisa S, Pozzatti R, Muschel RJ, Saffiotti U, Ballin M, Goldfarb RH, Khoury G, Liotta LA: Secretion of type IV collagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res 47: 1523–1528, 1987
Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS: β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236: 582–585, 1987
Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986
Fleischman LF, Chahwala SB, Cantley L:Ras-transformed cells: Altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites. Science 231: 407–410, 1986
Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987
Smith MR, DeGudicibus SJ, Stacey DW: Requirement for c-ras proteins during viral oncogene transformation. Nature 320: 540–543, 1986
Jaggi R, Salmons B, Muellener D, Groner B: The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR. EMBO J 5: 2609–2616, 1986
Rabin MS, Doherty PJ, Gottesman MM: The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes. Proc Natl Acad Sci USA 83: 357–360, 1986
Cline MJ, Battifora H, Yokota J: Proto-oncogene abnormalities in human breast cancer: Correlations with anatomic features and clinical course of disease. J Clin Oncol 5: 999–1006, 1987
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182, 1987
Kolata G: Oncogenes give breast cancer prognosis. Science 235: 160–161, 1987
van de Vijver M, van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R: Amplification of theneu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 7: 2019–2023, 1987
Agnantis NJ, Parissi P, Anagnostakis D, Spandidos DA: Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancer. Oncology 43: 36–39, 1986
Clair T, Miller WR, Cho-Chung YS: Prognostic significance of the expression of aras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res 47: 5290–5293, 1987
Horan Hand P, Vilasi V, Thor A, Ohuchi N, Schlom J: Quantitation of Harveyras p21 enhanced expression in human breast and colon carcinomas. J Natl Cancer Inst 79: 59–65, 1987
Lundy J, Grimson R, Mishriki Y, Chao S, Oravez S, Fromowitz F, Viola MV: Elevatedras oncogene expression correlates with lymph node metastases in breast cancer patients. J Clin Oncol 4: 1321–1325, 1986
Yokota J, Tsunetsugu-Yokota Y, Battifora H, Le Fevre C, Cline MJ: Alterations ofmyc, myb, andras Ha proto-oncogenes in cancers are frequent and show clinical correlation. Science 231: 261–265, 1986
Seeger RC, Broudeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111–1116, 1985
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124, 1984
Nau MM, Brooks BJ, Carney DN, Gazdar AF, Battey JF, Sausville EA, Minna JD: Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci USA 83: 1092–1096, 1986
Tsuboi K, Hirayoshi K, Takeuchi K, Sabe H, Shimada Y, Ohshio G, Tobe T, Hatanaka M: Expression of the c-myc gene in human gastrointestinal malignancies. Biochem Biophys Res Commun 146: 699–704, 1987
Lam WC, Delikatny JE, Orr FW, Wass J, Varani J, Ward PA: The chemotactic response of tumor cells: A model for cancer metastasis. Am J Pathol 104: 69–76, 1981
McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT: Stimulation of haptotaxis and migration of tumor cells by serum spreading factor. Cancer Metast Rev 4: 125–152, 1985
Stracke ML, Guirguis R, Liotta LA, Schiffmann E: Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. Biochem Biophys Res Commun 146: 339–345, 1987
Guirguis R, Margulies IMK, Taraboletti G, Schiffmann E, Liotta LA: Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration. Nature 329: 261–263, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liotta, L.A. Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res Tr 11, 113–124 (1988). https://doi.org/10.1007/BF01805835
Issue Date:
DOI: https://doi.org/10.1007/BF01805835